Literature DB >> 26764071

A Tale of 2 Diseases: The History of Long-QT Syndrome and Brugada Syndrome.

Ofer Havakuk1, Sami Viskin2.   

Abstract

The Brugada syndrome (BrS) and long-QT syndrome (LQTS) present as congenital or acquired disorders with diagnostic electrocardiograms (ST-segment elevation and prolonged QT interval, respectively) and increased risk for malignant arrhythmias. Our understanding of the 2 disease forms (congenital vs. acquired) differs. A female patient on quinidine for atrial fibrillation who develops ventricular fibrillation is diagnosed with "acquired LQTS" and is discharged with no therapy other than instructions to avoid QT-prolonging medications. In contrast, an asymptomatic male patient who develops a Brugada electrocardiogram on flecainide is diagnosed with "asymptomatic BrS" and could be referred for an electrophysiological evaluation that could result in defibrillator implantation. The typical patient undergoing defibrillator implantation for BrS is asymptomatic but has a Brugada electrocardiogram provoked by a drug. The authors describe how the histories of LQTS and BrS went through the same stages, but in different sequences, leading to different conclusions.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  electrocardiogram; history; ventricular fibrillation

Mesh:

Year:  2016        PMID: 26764071     DOI: 10.1016/j.jacc.2015.10.020

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  12 in total

1.  Tbx20 controls the expression of the KCNH2 gene and of hERG channels.

Authors:  Ricardo Caballero; Raquel G Utrilla; Irene Amorós; Marcos Matamoros; Marta Pérez-Hernández; David Tinaquero; Silvia Alfayate; Paloma Nieto-Marín; Guadalupe Guerrero-Serna; Qing-Hua Liu; Roberto Ramos-Mondragón; Daniela Ponce-Balbuena; Todd Herron; Katherine F Campbell; David Filgueiras-Rama; Rafael Peinado; José L López-Sendón; José Jalife; Eva Delpón; Juan Tamargo
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

2.  Brugada Syndrome: Defining the Risk in Asymptomatic Patients.

Authors:  Juan Sieira; Pedro Brugada
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

Review 3.  Pathogenesis and management of Brugada syndrome.

Authors:  Juan Sieira; Gregory Dendramis; Pedro Brugada
Journal:  Nat Rev Cardiol       Date:  2016-09-15       Impact factor: 32.419

Review 4.  Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

Authors:  Christopher L-H Huang
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

Review 5.  Electrophysiological Mechanisms of Brugada Syndrome: Insights from Pre-clinical and Clinical Studies.

Authors:  Gary Tse; Tong Liu; Ka H C Li; Victoria Laxton; Yin W F Chan; Wendy Keung; Ronald A Li; Bryan P Yan
Journal:  Front Physiol       Date:  2016-10-18       Impact factor: 4.566

6.  Who is the guilty among these two silent killers?

Authors:  Bortolo Martini; Claudio Zolla; Francesco Guglielmi; Gian Luca Toffanin; Sergio Cannas; Nicolò Martini; Rocco Arancio
Journal:  HeartRhythm Case Rep       Date:  2016-09-17

7.  Regulation of Na+ channel inactivation by the DIII and DIV voltage-sensing domains.

Authors:  Eric J Hsu; Wandi Zhu; Angela R Schubert; Taylor Voelker; Zoltan Varga; Jonathan R Silva
Journal:  J Gen Physiol       Date:  2017-02-23       Impact factor: 4.086

Review 8.  Calcium in Brugada Syndrome: Questions for Future Research.

Authors:  Michelle M Monasky; Carlo Pappone; Marco Piccoli; Andrea Ghiroldi; Emanuele Micaglio; Luigi Anastasia
Journal:  Front Physiol       Date:  2018-08-10       Impact factor: 4.566

Review 9.  Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery.

Authors:  Paola Imbrici; Antonella Liantonio; Giulia M Camerino; Michela De Bellis; Claudia Camerino; Antonietta Mele; Arcangela Giustino; Sabata Pierno; Annamaria De Luca; Domenico Tricarico; Jean-Francois Desaphy; Diana Conte
Journal:  Front Pharmacol       Date:  2016-05-10       Impact factor: 5.810

10.  Type-I Paradox of Brugada Syndrome.

Authors:  Sami Viskin; Aviram Hochstadt; Raphael Rosso
Journal:  J Am Heart Assoc       Date:  2018-05-10       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.